Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Neuroendocrine Tumor Treatment Market to Reach USD 4.24 Billion by 2032

Global Neuroendocrine Tumor Treatment Market Size Study, By Type (Meningiomas, Adrenal Cancer, Carcinoid Tumors, Paraganglioma), By Product (Somatostatin Analogs, Targeted Therapy, Others), By Site (Lung, Pancreas, Small Intestine, Stomach, Others), By End Use (Hospitals, Clinics, Others), and Regional Forecasts 2022-2032

Product Code: HLSDT-94164542
Publish Date: 13-01-2025
Page: 200

The global neuroendocrine tumor treatment market was valued at USD 2.51 billion in 2023 and is projected to grow at a CAGR of 6.0% during the forecast period 2024-2032, reaching a market size of USD 4.24 billion by 2032. This growth is primarily attributed to the increasing prevalence of neuroendocrine tumors, advancements in treatment modalities, and rising awareness among healthcare professionals and patients.
The escalating incidence of neuroendocrine tumors has spurred significant demand for innovative and effective treatment solutions. In the United States alone, over 12,000 new cases of neuroendocrine tumors are diagnosed annually, reflecting a growing need for advanced diagnostic tools and therapies. Additionally, breakthroughs such as Peptide Receptor Radionuclide Therapy (PRRT) are transforming the treatment landscape by enhancing therapeutic efficacy with fewer side effects compared to traditional methods.
Targeted therapies, especially Somatostatin Analogs (SSAs), have emerged as key contributors to market growth due to their proven ability to manage symptoms and control tumor progression. Pharmaceutical companies are heavily investing in research and development (R&D) to develop precision medicine solutions tailored to individual patient profiles, improving outcomes and fostering further innovation within the neuroendocrine tumor treatment industry.
Regional analysis reveals that North America dominated the market in 2024, holding a significant 42.1% revenue share, supported by advanced healthcare infrastructure and strong R&D activities. The Asia Pacific region is poised to witness the fastest growth rate due to expanding healthcare investments, growing awareness, and improved access to cutting-edge therapies in emerging economies such as China, India, and Japan.
Moreover, the rising adoption of outpatient care models has fueled growth within clinics, which are projected to grow at the highest CAGR over the forecast period. Patients increasingly prefer outpatient treatments for convenience, reduced costs, and shorter recovery periods, further driving the demand for advanced therapies.

Major Market Players Included in This Report
• Novartis AG
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Hutchison MediPharma Limited
• AVEO Pharmaceuticals, Inc.
• Ipsen Pharma
• Eli Lilly and Company
• Exelixis, Inc.
• Jubilant Pharmova Limited
• Advanced Accelerator Applications
• AstraZeneca PLC
• Merck & Co., Inc.
• Roche Holding AG
• Medtronic PLC
The Detailed Segments and Sub-Segments of the Market Are Explained Below
By Type:
• Meningiomas
• Adrenal Cancer
• Carcinoid Tumors
• Paraganglioma
• Pheochromocytoma
• Others
By Product:
• Somatostatin Analogs (SSAs)
• Targeted Therapy
• Others
By Site:
• Lung
• Pancreas
• Small Intestine
• Stomach
• Colon
• Rectum
• Others
By End Use:
• Hospitals
• Clinics
• Others
By Region:
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Norway
o Denmark
o Sweden
• Asia Pacific
o Japan
o China
o India
o South Korea
o Australia
o Singapore
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

Years Considered for the Study
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024-2032
Key Takeaways
• Rising prevalence of neuroendocrine tumors and advancements in targeted therapies are driving market growth.
• North America holds the largest share, while Asia Pacific is expected to grow at the fastest pace.
• Somatostatin Analogs (SSAs) dominate the product segment, driven by their efficacy in managing tumor progression.
• Increasing preference for outpatient care and investments in precision medicine are key growth drivers.

Table of Contents
Chapter 1. Global Neuroendocrine Tumor Treatment Market Executive Summary
1.1. Global Neuroendocrine Tumor Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Product
1.3.3. By Site
1.3.4. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Neuroendocrine Tumor Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Neuroendocrine Tumor Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of neuroendocrine tumors
3.1.2. Advancements in targeted therapies and precision medicine
3.1.3. Rising R&D investments in oncology
3.2. Market Challenges
3.2.1. High cost of treatments and diagnostic tools
3.2.2. Limited awareness in emerging regions
3.3. Market Opportunities
3.3.1. Emerging healthcare infrastructure in Asia Pacific and Latin America
3.3.2. Technological advancements in diagnostic imaging and therapies
Chapter 4. Global Neuroendocrine Tumor Treatment Market Industry Analysis
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Key Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Neuroendocrine Tumor Treatment Market Size & Forecast by Type, 2022-2032
5.1. Segment Dashboard
5.2. Global Neuroendocrine Tumor Treatment Market Revenue Trend Analysis, 2022-2032 (USD Billion)
5.2.1. Meningiomas
5.2.2. Adrenal Cancer
5.2.3. Carcinoid Tumors
5.2.4. Paraganglioma
5.2.5. Pheochromocytoma
5.2.6. Others
Chapter 6. Global Neuroendocrine Tumor Treatment Market Size & Forecast by Product, 2022-2032
6.1. Segment Dashboard
6.2. Global Neuroendocrine Tumor Treatment Market Revenue Trend Analysis, 2022-2032 (USD Billion)
6.2.1. Somatostatin Analogs (SSAs)
6.2.2. Targeted Therapy
6.2.3. Others
Chapter 7. Global Neuroendocrine Tumor Treatment Market Size & Forecast by Site, 2022-2032
7.1. Segment Dashboard
7.2. Global Neuroendocrine Tumor Treatment Market Revenue Trend Analysis, 2022-2032 (USD Billion)
7.2.1. Lung
7.2.2. Pancreas
7.2.3. Colon
7.2.4. Small Intestine
7.2.5. Rectum
7.2.6. Stomach
7.2.7. Others
Chapter 8. Global Neuroendocrine Tumor Treatment Market Size & Forecast by End Use, 2022-2032
8.1. Segment Dashboard
8.2. Global Neuroendocrine Tumor Treatment Market Revenue Trend Analysis, 2022-2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Others
Chapter 9. Global Neuroendocrine Tumor Treatment Market Size & Forecast by Region, 2022-2032
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Norway
9.2.7. Denmark
9.2.8. Sweden
9.3. Asia Pacific
9.3.1. Japan
9.3.2. China
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Singapore
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Novartis AG
10.1.2. Pfizer Inc.
10.1.3. Bristol-Myers Squibb Company
10.2. Top Market Strategies
10.3. Company Profiles
Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, and others.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now